SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-008703
Filing Date
2022-05-10
Accepted
2022-05-10 06:52:40
Documents
59
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q reta-20220331.htm   iXBRL 10-Q 1553500
2 EX-10.1 reta-ex10_1.htm EX-10.1 29295
3 EX-10.2 reta-ex10_2.htm EX-10.2 26202
4 EX-31.1 reta-ex31_1.htm EX-31.1 21536
5 EX-31.2 reta-ex31_2.htm EX-31.2 21693
6 EX-32.1 reta-ex32_1.htm EX-32.1 12687
7 EX-32.2 reta-ex32_2.htm EX-32.2 12770
8 GRAPHIC img70967532_0.jpg GRAPHIC 55055
9 GRAPHIC img70967532_1.jpg GRAPHIC 26145
10 GRAPHIC img70967532_2.jpg GRAPHIC 77701
  Complete submission text file 0000950170-22-008703.txt   5314791

Data Files

Seq Description Document Type Size
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT reta-20220331_def.xml EX-101.DEF 130499
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT reta-20220331.xsd EX-101.SCH 42084
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT reta-20220331_pre.xml EX-101.PRE 223846
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT reta-20220331_cal.xml EX-101.CAL 33810
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT reta-20220331_lab.xml EX-101.LAB 324192
53 EXTRACTED XBRL INSTANCE DOCUMENT reta-20220331_htm.xml XML 616610
Mailing Address 5320 LEGACY DRIVE PLANO TX 75024
Business Address 5320 LEGACY DRIVE PLANO TX 75024 972-865-2219
REATA PHARMACEUTICALS INC (Filer) CIK: 0001358762 (see all company filings)

IRS No.: 113651945 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37785 | Film No.: 22907273
SIC: 2834 Pharmaceutical Preparations